GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Most recently in November 2022, Wei and colleagues [82] evaluated mice with T2DM on a high-sugar and high-fat diet for changes in retinal structure following GLP-1RA treatment
Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: target trial emulation using real-world data
Compounded versions of GLP-1 receptor agonists are not FDA-approved and can increase the risk of contamination when purchased from unreliable sources
Our team of specialists at NuLife Health & Wellness works closely with you to determine the best treatment plan based on your health needs and goals
Our clinicians can help review your medical history, baseline labs, medication eligibility, insurance pathway, side-effect concerns, and long-term maintenance plan